Activation of the PI3K/AKT Signaling Pathway by ARNTL2 Enhances Cellular Glycolysis and Sensitizes Pancreatic Adenocarcinoma to Erlotinib

Investigators examined the levels of various cancer hallmarks and identified glycolysis as the primary risk factor for overall survival in pancreatic cancer.